{{Rsnum
|rsid=29880
|Chromosome=7
|position=40914882
|Orientation=plus
|GMAF=0.1501
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.2 | 23.0 | 1.8
| HCB | 77.4 | 22.6 | 0.0
| JPT | 69.9 | 28.3 | 1.8
| YRI | 49.7 | 44.9 | 5.4
| ASW | 50.9 | 47.4 | 1.8
| CHB | 77.4 | 22.6 | 0.0
| CHD | 87.2 | 12.8 | 0.0
| GIH | 78.2 | 19.8 | 2.0
| LWK | 55.5 | 38.2 | 6.4
| MEX | 81.0 | 19.0 | 0.0
| MKK | 51.3 | 42.9 | 5.8
| TSI | 72.5 | 22.5 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs29880
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 459 twin pairs; Replication Sample Size: NR); (Region: 7p14.1; Reported Gene(s): Q4KMW4; Risk Allele: rs29880-?); (p-value= 0.000007).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740116
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs29880
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}